Who
Robert B. Ford
Chairman and CEO
Company insider
Files Form 4 as: Chairman and CEO, Abbott Laboratories.
In numbers
- Trades disclosed
- 156
- Buys
- 2
- Sells
- 7
- Bought
- $4.5M
- Sold
- $162.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jul 2014
- Last trade
- 25 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code M | $6.7M151,869 at $44.40 | filing |
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code M | $14.8M246,963 at $59.94 | filing |
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $25.3M218,535 at $115.57 | filing |
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code M | —151,869 at $0.00 | filing |
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code M | —246,963 at $0.00 | filing |
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $20.9M180,297 at $116.19 | filing |
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code M | —151,869 at $0.00 | filing |
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code M | —246,963 at $0.00 | filing |
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code M | $6.7M151,869 at $44.40 | filing |
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code M | $14.8M246,963 at $59.94 | filing |
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $25.3M218,535 at $115.57 | filing |
| 25 Aug 2026filed 27 Aug 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $20.9M180,297 at $116.19 | filing |
| 27 Feb 2026filed 3 Mar 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $3.5M30,308 at $116.26 | filing |
| 27 Feb 2026filed 3 Mar 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $3.5M30,308 at $116.26 | filing |
| 24 Feb 2026filed 26 Feb 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —83,464 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —344,066 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —344,066 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —83,464 at $0.00 | filing |
| 23 Jan 2026filed 26 Jan 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Bought | $2.0M18,800 at $107.13 | filing |
| 23 Jan 2026filed 26 Jan 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Bought | $2.0M18,800 at $107.13 | filing |
News
Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?ABT · fool.com · 24 Oct 2026Tag: abbott_laboratories_settlementABT · newsroomamerica.com · 24 Oct 2026Abbott Laboratories announces a baby formula spinoff companyABT · marketplace.org · 21 Oct 2026
0 headlines in the last 90 days name Robert B. Ford; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.